PRINCETON, N.J.— November 3, 2022 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that eight of the Company’s scientists have been featured in a list of the top 2% of scientists worldwide. The list was published in mid-October 2022 by Elsevier BV and Stanford University.
The ranking of scientists worldwide is based on a composite citation score or a percentile rank of 2% or above. Scientists are classified into 22 scientific fields and 175 sub-fields. The eight Certara scientists, who were ranked on the list, were recognized in the fields of toxicology, pharmacology & pharmacy, and neurology & neurosurgery.
“Congratulations to our scientific leaders for receiving this prestigious recognition for their significant contributions to pharmaceutical sciences. Their research has had a positive impact on drug development and ultimately patients,” said William F. Feehery, Ph.D., chief executive officer of Certara. “Science is at the heart of Certara’s mission. Our team includes some of the world’s leading scientists working on the toughest drug development challenges today.”
About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services that transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.